(Reuters) - NimbleGen is active in high-density DNA microarrays, which
are a widely used discovery and research tool in pharma research
for the understanding of genetic causes of disease and
predisposition factors.
Read more at Reuters.com Mergers News
are a widely used discovery and research tool in pharma research
for the understanding of genetic causes of disease and
predisposition factors.
Read more at Reuters.com Mergers News
No comments:
Post a Comment